- Type
- not stated
- Format
- Multimodal, predominantly Tabular — clinical trial datasets (CDISC-shaped), claims/registry-derived comparator cohorts, programme enrolment and dispensing/adherence tables — plus Text from medical-writing, safety narrative and patient-professional programme records
- Volume
- Not disclosed. Bounded read from scale proxies: a ~$608M revenue provider with ~980 staff running regulated programmes and biometrics for large-pharma clients implies patient-level data across many millions of programme enrolments and thousands of studies cumulatively — but every one of those records is sponsor-contracted, so no single aggregate corpus is available to a buyer
- Users
- N/A — a services organisation, not a platform with registered users; the relevant population is programme participants (patients enrolled in the risk-management and patient-support programmes it operates) plus sponsor clients. Sponsor base is large-pharma and mid-cap biotech; participant counts across programmes are not disclosed on this page and would be the key number to request
- History
- 20 years
- Update frequency
- not stated
- Growth
- Active — continuing content and service-line expansion across regulatory, biometrics, data science, safety and specialty areas (including a dedicated emerging-therapeutics service line), a public-company acquisition-financed growth history, and a maintained case-study/perspectives publishing programme
- Launched
- ~1994-1996 for the founding clinical-data-management business; the data-heavy risk-management/patient-support programme line and the real-world-evidence/synthetic-control capability were layered on later, and the group has grown substantially through acquisitions
- Delivery
- not stated
- Entity mapping
- not stated
- Sample
- not stated
- Point-in-time
- not stated
- Licence
- not stated